Mucosal surfaces must allow the exchange of metabolites required for life into the host and excretion/exclusion of wastes and toxins out of the host, while also maintaining a first line of defense against invasive microbes. However, mucosal inflammation, elicited to combat microbial infection, can also damage the integrity of the mucosal barrier, if not controlled. Many mucosal surfaces are in constant or transient contact with microbes, yet the molecular mechanisms governing the extent of the inflammatory response at the mucosal surface, the healing of the surface after insults and the molecular basis of remodeling changes that affect subsequent mucosal function and inflammatory responses are poorly understood. This proposal will investigate these mechanisms by assembling an experienced team of investigators with diverse and complimentary expertise to further our understanding of the mucosal immune defense mechanisms of the urinary bladder against bacterial infection. Analysis of the bladder mucosal responses to the most common cause of urinary tract infection (UTI), E. coli, in distantly related inbred mouse strains has identified patterns of response that correlate with resistance or susceptibility to both initial and secondary infections. The proposed research will probe differences in the immune defense pathways of the bladder mucosa during acute and recurrent infection, providing critical insights in the field of mucosal immunology and the role of epithelial cells in mucosal response. These studies will specifically investigate the role of bladder mucosal remodeling in modulating innate signaling pathways in previously infected mice (Aim 1) and investigate the protective (Aim 2) and damaging (Aim 3) mechanisms of the acute bladder inflammatory response in nave mice. These responses correlate with outcomes of disease and subsequent remodeling of the bladder tissue, which in turn affects subsequent infections. Understanding immune responses of previously infected vs. nave mucosal tissues will likely give important insights into clinical disease, in which patients over their life-time have undoubtably suffered from multiple sequential infections. These investigations will reveal new details of the mechanisms of mucosal defense against bacteria, broadening the understanding of the regulation of mucosal inflammation and the signaling between mucosal epithelia and immune cells, and thus advance our understanding of acute and recurrent infection susceptibility and protection, in this age of increasing microbial antibiotic resistance. These insights will contribute to the development of novel vaccines and immunomodulatory therapeutics targeting the mucosa.

Public Health Relevance

The goal of this research is to reveal new mechanisms of mucosal defense against bacteria. Such findings will advance our understanding of both protective and damaging inflammatory responses at the mucosa, potentially contributing to the design of vaccines and raising new avenues for therapeutic intervention in mucosal infections and chronic inflammatory diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI095542-09
Application #
9724328
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Rothermel, Annette L
Project Start
2011-07-05
Project End
2021-06-30
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
9
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Washington University
Department
Pathology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Colonna, Marco (2018) Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity. Immunity 48:1104-1117
Cervantes-Barragan, Luisa; Colonna, Marco (2018) Chemical sensing in development and function of intestinal lymphocytes. Curr Opin Immunol 50:112-116
Bando, Jennifer K; Gilfillan, Susan; Song, Christina et al. (2018) The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells. Immunity 48:1208-1219.e4
Robinette, M L; Cella, M; Telliez, J B et al. (2018) Jak3 deficiency blocks innate lymphoid cell development. Mucosal Immunol 11:50-60
Kalas, Vasilios; Pinkner, Jerome S; Hannan, Thomas J et al. (2017) Evolutionary fine-tuning of conformational ensembles in FimH during host-pathogen interactions. Sci Adv 3:e1601944
Cortez, Victor S; Ulland, Tyler K; Cervantes-Barragan, Luisa et al. (2017) SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-? signaling. Nat Immunol 18:995-1003
Cervantes-Barragan, Luisa; Chai, Jiani N; Tianero, Ma Diarey et al. (2017) Lactobacillus reuteri induces gut intraepithelial CD4+CD8??+ T cells. Science 357:806-810
Schreiber 4th, Henry L; Conover, Matt S; Chou, Wen-Chi et al. (2017) Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections. Sci Transl Med 9:
Bando, Jennifer K; Colonna, Marco (2016) Innate lymphoid cell function in the context of adaptive immunity. Nat Immunol 17:783-9
Cortez, Victor S; Colonna, Marco (2016) Diversity and function of group 1 innate lymphoid cells. Immunol Lett 179:19-24

Showing the most recent 10 out of 39 publications